DIA 2013 49th Annual Meeting
Click here to go to the previous page
Narrative Medicine and Pharmacovigilance
Track : Track 14: Clinical Safety and Pharmacovigilance
Program Code: 117
Date: Monday, June 24, 2013
Time: 11:00 AM to 12:30 PM  EST
Location: 152
CHAIR :
 Michael A. Ibara, PharmD (SCHNON), Head of Business Development Coordination & Innovation, WW Safety & Regulatory, Pfizer Inc, United States
SPEAKER (S):
 Jesus Rivera, MSc (SPKNON), Senior Learning Manager, Bristol-Myers Squibb Company, United States
Allison Salke, MBA (SPKNON), Tombolo, Inc., United States
Description
In recent years, pharmacovigilance has emphasized the collection and submission of tabular data. Using ideas from narrative medicine, we can re-focus on the patient's story to better understand adverse drug reactions and benefit-risk balance.